Cidara Therapeutics Inc
NASDAQ:CDTX 11:22:35 AM EDT
Earnings Announcements
Cidara Therapeutics Reports First Quarter 2022 Financial Results
Published: 05/11/2022 21:46 GMT
Cidara Therapeutics Inc (CDTX) - Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results.
Qtrly Loss per Share $0.27.
Q1 Earnings per Share View $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $0.27.
Q1 Earnings per Share View $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.21 Million
Adjusted EPS is expected to be -$0.29
Next Quarter Revenue Guidance is expected to be $5.92 Million
Next Quarter EPS Guidance is expected to be -$0.28
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.29
Next Quarter Revenue Guidance is expected to be $5.92 Million
Next Quarter EPS Guidance is expected to be -$0.28
More details on our Analysts Page.